+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rx/Reimbursement Adult Incontinence in Sweden

  • ID: 4517586
  • Report
  • June 2020
  • Region: Sweden
  • 20 pages
  • Euromonitor International
The growth in rx/reimbursement adult incontinence is, as with retail adult incontinence, stimulated by a growing and ageing population in Sweden. The risk of being affected by incontinence concerns increases considerably the older a person gets, and it is estimated by the Swedish Medical Products Agency that half of the costs for rx/reimbursement adult incontinence products are related to people that are 80 years or older.

The Rx/Reimbursement adult incontinence in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Total Adult Incontinence.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
List of Contents and Tables

HEADLINES

PRE-COVID-19 PERFORMANCE
  • Ageing population helps drive continued growth in rx/reimbursement adult incontinence
  • Stigma hinders rx/reimbursement adult incontinence growth
  • Societal acceptance the key to growth
2020 AND BEYOND
  • COVID-19 impact
  • Recovery and opportunities
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024

EXECUTIVE SUMMARY
  • COVID-19 impact on tissue and hygiene
  • COVID-19 country impact
  • Consumers increasingly looking for sustainable or green products
  • Private label holds the biggest share of retail sales; e-commerce continues to grow
  • Retail sales will rebound from the COVID-19 hit, AFH will struggle to offset the 2020 damage to its sales
Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2016-2024
Chart 2 Tissue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024

MARKET INDICATORS
Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024

MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES
Summary 1 Research Sources
Note: Product cover images may vary from those shown
Adroll
adroll